New study tests herbal vs standard drug for chemo side effect
NCT ID NCT07578064
First seen May 13, 2026 · Last updated May 13, 2026
Summary
This study aims to see if a Chinese herbal medicine (Shengbai Oral Liquid) works better than a standard drug (Leucogen) at raising low white blood cell counts caused by cancer treatments. About 60 breast cancer patients will take both treatments in different cycles to compare their effects. The goal is to find a gentler way to manage this common side effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.